In this webinar, Ronan Chaligné, director of the Single Cell Research Initiative at MSK, shares common challenges that he has encountered when building a clinical sample cohort. He speaks to different technologies that have been adopted over the years to serve the needs of the Single Cell Research Initiative, including the use of levitation technology as an alternative to fluorescence-activated cell sorting (FACS).

About Dr. Ronan Chaligné:

Director, Single Cell Research Initiative & Assistant Lab Member,
Sloan Kettering Institute

Ronan Chaligné is the director of the Single Cell Research Initiative and an assistant member of the Pe’er lab at Memorial Sloan Kettering Cancer Center (MSK). Chaligné received his Master of Science degree in cell biology at Université Val d’Essonne in Évry, France, and his doctorate at Institut Gustave Roussy in Villejuif, France. He completed postdoctoral work at Institut Curie in Paris and Weill Cornell Medicine in New York City. His research interests include the pathways and epigenetic factors involved in the initiation and propagation of malignancies. In his current position at MSK, he aims to dissect genetic and epigenetic mechanisms of cancer and development at the single-cell level.

Applications: Single-Cell, Oncology

Key takeaways:

• Hear about the challenges associated with building a clinical sample cohort
• Overview of various technologies adopted to serve the needs of the Single Cell Research Initiative
• Use of Levitation Technology as an alternative to fluorescence-activated cell sorting (FACS)